Clinical Trial Update: Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating chloroquine as an anti-autophagy agent in stage IV small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Small Cell Lung Cancer | Phase 1 | Status: TERMINATED